GAG
AZN icon

Goodman Advisory Group’s AstraZeneca AZN Stock Holding History

Goodman Advisory Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,601
Closed -$1.5M – 64
2024
Q3 		$1.5M Sell
9,601
-141
-1% -$22.8K 0.43% 48
2024
Q2 		$1.52M Buy
+9,742
New +$1.47M 0.45% 46

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goodman Advisory Group's AZN Position: Q4 2024 in Review

Goodman Advisory Group sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 9,601 shares — an estimated $1.5M sold.

Goodman Advisory Group first reported a position in AZN in Q2 2024 and held it in 2 quarters. The position peaked at $1.52M in Q2 2024. 1,218 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Goodman Advisory Group reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
  • Goodman Advisory Group sold 9,601 AstraZeneca shares in Q4 2024, an estimated $1.5M.
  • Goodman Advisory Group first reported a position in AstraZeneca in Q2 2024 and held it in 2 quarters.
  • Goodman Advisory Group's AstraZeneca position peaked at $1.52M in Q2 2024.
  • 1,218 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Goodman Advisory Group's 13F filing for Q4 2024, filed 13 Feb 2025.